Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-15-012301)

Filing Details

Accession Number:: 0001179110-15-012301
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-08-18 20:30:16
Reporting Period:: 2015-08-18

Filing Date:: 2015-08-18
Accepted Time:: 2015-08-18 20:30:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1583107	Theravance Biopharma Inc.	TBPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1596187	Junning Lee	C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd. South San Francisco CA 94080	Sr. Vp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2015-08-18	9,000	$12.90	9,000	No	4	P	Indirect	By spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	169,720	Direct

Footnotes

By Spouse as holder of self directed retirement account. Reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein.